Skip to content

Johnson & Johnson JNJ MEDTECH — Total Assets

Other segment segments

Innovative Medicine
$78.12B+33.0%
General Corporate
$36.6B-26.6%

Similar metrics at other companies

Knowles logo
KNMedTech & Specialty Audio — Total Assets
$388.5M-2.0%
Abbott logo
ABTMedical Devices — Total Assets
$10.98B+9.5%
Duos Technologies Group, Inc. logo
DUOTTechnologies — Total Assets
$2.77M-76.1%
Asset Entities logo
ASSTMedical Device — Total Assets
$17.63M
DexCom logo
DXCMTotal Assets
$6.63B-1.8%
IDEX logo
IEXHealth & Science Technologies — Total Assets
$4.29B+2.6%

Other financials

Income statement

See full
Revenue$24.1B+9.9%
Gross profit$16.0B+9.8%
Operating income$6.3B+2.3%
Net income$5.2B-52.4%
EPS (diluted)$2.14-52.9%

Balance sheet

See full
Cash & equivalents$21.7B-43.6%
Total debt$55.0B+5.2%
Total equity$81.2B+3.9%
Total assets$200.89B+3.7%

Cash flow

See full
Operating cash flow$2.5B-39.8%
CapEx$1.0B+31.9%
Free cash flow$1.5B-56.6%

Valuation

See full
Market cap$623.71B+66.9%
Enterprise value$657.01B+61.9%
P/E29.6×+13.2×
P/S6.5×+2.3×

Profitability

See full
Gross margin67.8%-0.5pp
Operating margin26.4%+2.8pp
Net margin21.8%-2.6pp
FCF margin18.5%-4.3pp

Returns & leverage

See full
Return on equity26.4%-3.0pp
Debt / equity0.7×0.0×
Current ratio-0.2×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Johnson & Johnson’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's medtech — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Johnson & Johnson's MEDTECH — total assets?
Johnson & Johnson (JNJ) reported MEDTECH — total assets of $86.18B in Q1 2026.
How has Johnson & Johnson's MEDTECH — total assets changed year-over-year?
Johnson & Johnson's MEDTECH — total assets increased by 1.3% year-over-year, from $85.11B to $86.18B.
What does MEDTECH — total assets mean?
This represents the total book value of resources owned or controlled by the medical technology segment, including inventory, property, equipment, and intangible assets. It provides a measure of the capital base required to support the segment's revenue generation. Analysts use this to calculate return on assets and assess capital intensity.